Forma Therapeutics Holdings Inc. (FMTX): Price and Financial Metrics
FMTX Price/Volume Stats
| Current price | $20.01 | 52-week high | $20.68 |
| Prev. close | $19.98 | 52-week low | $4.95 |
| Day low | $19.98 | Volume | 739,100 |
| Day high | $20.01 | Avg. volume | 847,595 |
| 50-day MA | $16.65 | Dividend yield | N/A |
| 200-day MA | $10.81 | Market Cap | 957.54M |
FMTX Stock Price Chart Interactive Chart >
Forma Therapeutics Holdings Inc. (FMTX) Company Bio
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
FMTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 40.92% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -59.26% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...